Drug intelligence / Profile preview

Somaphen

Development stage
Unknown
Lead developer
Alexandria for Pharmaceuticals and Chemical Industries
Modality
Small Molecules
01

Overview

Somaphen is a fixed-dose combination pharmaceutical product primarily used as a skeletal muscle relaxant and analgesic for the treatment of acute musculoskeletal pain and spasms. It contains three active ingredients: carisoprodol, paracetamol (acetaminophen), and caffeine. Carisoprodol is a centrally acting muscle relaxant that is metabolized into meprobamate, which acts as a positive allosteric modulator at the GABA-A receptor, thereby inhibiting interneuronal transmission in the spinal cord and reticular formation. Paracetamol provides analgesic and antipyretic effects, likely through the inhibition of prostaglandin synthesis within the central nervous system. Caffeine is included as an adjuvant to enhance the analgesic efficacy of paracetamol and to mitigate the sedative effects commonly associated with carisoprodol. This combination is typically administered orally and is indicated for short-term relief of painful musculoskeletal conditions.

Brand names
Somaphen
Other names
carisoprodol + paracetamol + caffeine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)

Beyond the preview

Go deeper on Somaphen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somaphen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call